DE3686113D1 - Lymphokin, dessen herstellung und verwendungen. - Google Patents

Lymphokin, dessen herstellung und verwendungen.

Info

Publication number
DE3686113D1
DE3686113D1 DE8686307198T DE3686113T DE3686113D1 DE 3686113 D1 DE3686113 D1 DE 3686113D1 DE 8686307198 T DE8686307198 T DE 8686307198T DE 3686113 T DE3686113 T DE 3686113T DE 3686113 D1 DE3686113 D1 DE 3686113D1
Authority
DE
Germany
Prior art keywords
lymphokin
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8686307198T
Other languages
English (en)
Other versions
DE3686113T2 (de
Inventor
Masakazu Mitsuhashi
Masashi Kurimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Original Assignee
Hayashibara Seibutsu Kagaku Kenkyujo KK
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Seibutsu Kagaku Kenkyujo KK, Hayashibara Biochemical Laboratories Co Ltd filed Critical Hayashibara Seibutsu Kagaku Kenkyujo KK
Application granted granted Critical
Publication of DE3686113D1 publication Critical patent/DE3686113D1/de
Publication of DE3686113T2 publication Critical patent/DE3686113T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/837—Lymph; lymph-glands; thymus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE8686307198T 1985-09-18 1986-09-18 Lymphokin, dessen herstellung und verwendungen. Expired - Fee Related DE3686113T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60205537A JPH0631318B2 (ja) 1985-09-18 1985-09-18 新リンホカインｉｉｉとその製法

Publications (2)

Publication Number Publication Date
DE3686113D1 true DE3686113D1 (de) 1992-08-27
DE3686113T2 DE3686113T2 (de) 1993-01-07

Family

ID=16508530

Family Applications (2)

Application Number Title Priority Date Filing Date
DE8686307198T Expired - Fee Related DE3686113T2 (de) 1985-09-18 1986-09-18 Lymphokin, dessen herstellung und verwendungen.
DE198686307198T Pending DE216605T1 (de) 1985-09-18 1986-09-18 Lymphokin, dessen herstellung und verwendungen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE198686307198T Pending DE216605T1 (de) 1985-09-18 1986-09-18 Lymphokin, dessen herstellung und verwendungen.

Country Status (6)

Country Link
US (1) US4994556A (de)
EP (1) EP0216605B1 (de)
JP (1) JPH0631318B2 (de)
KR (1) KR950008569B1 (de)
CA (1) CA1295241C (de)
DE (2) DE3686113T2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6096301A (en) * 1986-10-10 2000-08-01 Industria Farmaceutica Serono Spa Combined interferon/antiestrogen therapy for treatment of breast cancer
KR100569609B1 (ko) 2004-07-20 2006-05-02 (주)이노셀 세포면역치료제의 제조를 위한 림프구 장기 보관 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58146293A (ja) * 1982-02-26 1983-08-31 Mochida Pharmaceut Co Ltd 抗腫瘍性糖蛋白質の製造方法
US4481137A (en) * 1982-02-26 1984-11-06 Mochida Pharmaceutical Co., Ltd. Glycoproteins and processes for their production
ZA834976B (en) * 1982-07-30 1984-08-29 Genentech Inc Human lymphotoxin
US4758549A (en) * 1983-12-13 1988-07-19 Kabushiki Kaisha Mayashibara Seibutsu Kagaku Kenkyujo Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses
JPS60146228A (ja) * 1984-01-10 1985-08-01 Ricoh Co Ltd 液晶表示素子
EP0178050A1 (de) * 1984-08-13 1986-04-16 The Wellcome Foundation Limited Eiweisssubstanz
JPS6197224A (ja) * 1984-10-19 1986-05-15 Eisai Co Ltd 新規なリンホカイン
EP0205038A1 (de) * 1985-05-29 1986-12-17 Suntory Limited Polypeptid, Verfahren zu dessen Herstellung, Mikroorganismus und pharmazeutische Verwendung
JPS6248634A (ja) * 1985-07-23 1987-03-03 Mochida Pharmaceut Co Ltd 新規アミノ酸組成物、その製造方法及び該アミノ酸組成物を含有する医療組成物

Also Published As

Publication number Publication date
KR870003194A (ko) 1987-04-15
DE3686113T2 (de) 1993-01-07
DE216605T1 (de) 1987-09-03
KR950008569B1 (ko) 1995-08-03
CA1295241C (en) 1992-02-04
EP0216605A2 (de) 1987-04-01
EP0216605A3 (en) 1989-03-22
JPH0631318B2 (ja) 1994-04-27
EP0216605B1 (de) 1992-07-22
US4994556A (en) 1991-02-19
JPS6267026A (ja) 1987-03-26

Similar Documents

Publication Publication Date Title
DE3687646D1 (de) Biosensor und dessen herstellung.
DE68924026D1 (de) Biosensor und dessen herstellung.
DE3682654D1 (de) Acylaminosiliciumverbindungen, deren verwendung und herstellung.
DE3684948D1 (de) Imidderivate, ihre herstellung und anwendung.
ATE40365T1 (de) 3-acylaminomethylimidazo (1,2-a> pyridine, dessen herstellung und therapeutische anwendung.
DE69015788D1 (de) Thermistor und dessen herstellung.
DE3878340D1 (de) Kristalliner l-carnosin-zink-komplex und dessen herstellung.
DE3685282D1 (de) Rhombohedrisches polykristallines bornitrid und dessen herstellung.
DE3668891D1 (de) Benzothiazolone, ihre herstellung und anwendung.
DE3687130D1 (de) Pyrazolderivate, deren herstellung und verwendung.
DE3689919D1 (de) Polyfluorisoxazolamine, ihre Herstellung und Anwendung.
DE3671426D1 (de) Dipropargyloxybenzolverbindungen und deren herstellung.
DE3581210D1 (de) Immunotoxin und herstellung.
DE3673587D1 (de) Magnetronanode und deren herstellung.
DE3682882D1 (de) Menschliches immunoglobulin-g-fc-region-protein und dessen herstellung.
DE3674789D1 (de) Balken und dessen herstellung.
DE3586952T2 (de) Fibrinophiler urokinase-komplex und dessen herstellung.
DE3677157D1 (de) Saugfaehige binden und deren herstellung.
DE3381139D1 (de) Antibiotikum tan-420, dessen herstellung und anwendung.
DE3879328D1 (de) Stannosilikate, ihre herstellung und verwendung.
DE3584156D1 (de) Gif-2 und dessen herstellung.
DE3688883D1 (de) Strukturmaterial und dessen herstellung.
DE3676256D1 (de) 3',4'-dideoxy-3'-fluorkanamycin b und dessen herstellung.
DE3782698T2 (de) 5-fluoruridin-derivat und dessen herstellung.
DE3686113D1 (de) Lymphokin, dessen herstellung und verwendungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee